Stock CBSC CB SCIENTIFIC, INC.
Add to a list
To use this feature you must be a member
Log inSign up

CB Scientific, Inc. Stock

Equities

CBSC

US12506E1038

Market Closed - OTC Markets
Other stock markets
 13:17:42 2024-05-01 EDT 		5-day change 1st Jan Change
0.085 USD +0.35% Intraday chart for CB Scientific, Inc. +41.67% -22.73%
2022 CB Scientific, Inc. Announces FDA 510(k) Submission of Enhanced myCam Cardiac Event Monitor CI
2022 CB Scientific, Inc. Appoints James Ott as Chief Technology Officer CI

Chart CB Scientific, Inc.

Dynamic Chart

Latest news about CB Scientific, Inc.

CB Scientific, Inc. Announces FDA 510(k) Submission of Enhanced myCam Cardiac Event Monitor CI
CB Scientific, Inc. Appoints James Ott as Chief Technology Officer CI
CB Scientific, Inc. Appoints Paul Danner as Chairman CI
CB Scientific, Inc. Announces Appointment of Jeslie Chui as New Director for Asia Pacific CI
CB Scientific, Inc. has signed a definitive agreement to acquire Cardiolink Corporation. CI
CB Scientific. Inc. Announces Addition of Dozens of New Device Clinical Trials of my-Cam Device and New Hospital Monitoring Contracts Through Mango Wellness Co., Ltd. and My Cardia Thailand Co., Ltd CI
CB Scientific, Inc. entered into an agreement to acquire Datrix, LLC for $2.1 million. CI
CB Scientific, Inc. Announces the Launch of My-Cardia ECG Products and Services in Thailand CI
CB Scientific, Inc. acquired Operating Business Assets of Prevent Health Care International Corp. from Prevent Health Care International Corp. CI
Apotheca Biosciences, Inc. Agrees to Exclusive License Agreement with CB Scientific CI
Apotheca Biosciences and CB Scientific Joint Venture to Market Hemp CBD Infused Energy & Chill Drinks Under Brands DAVA & Magic Dragon High CI
FutureLand, Corp. acquired 20% stake in Apotheca Biosciences, Inc. from CB Scientific, Inc.. CI
CB Scientific, Inc. Develops three Core Platform Technologies; CannaRAPID, CannaNASAL, and CannaDERME, Focused on Precise Dosing and Controlled Release of Cannabinoid Compounds for Patients CI
CB Scientific, Inc. Develops CannaRAPID, CannaNASAL and CannaDERME CI
CB Scientific, Inc. Develops Cannabinoid Delivery Technologies: CannaRAPID(TM), CannaNASAL(TM) and CannaDERME(TM) CI
More news

Press releases CB Scientific, Inc.

CB Scientific, Inc. 2023 Year in Review AQ
CB Scientific : Entry into Material Definitive Agreement PU
CB Scientific : For the Period Ending June 30, 2022 PU
CB Scientific : As of August 12, 2022 PU
CB Scientific : For the Annual Report for the Fiscal Year Ended March 31, 2022 PU
More press releases

Quotes and Performance

1 day+0.35%
1 week+41.67%
Current month+34.92%
1 month+37.10%
3 months+4.94%
6 months-35.16%
Current year-22.73%
More quotes

Highs and lows

1 week
0.06
Extreme 0.06
0.09
1 month
0.05
Extreme 0.051
0.09
Current year
0.04
Extreme 0.04
0.12
1 year
0.04
Extreme 0.04
0.19
3 years
0.00
Extreme 0
1.04
5 years
0.00
Extreme 0
2.50
10 years
0.00
Extreme 0
4.01
More quotes

Managers and Directors - CB Scientific, Inc.

Managers TitleAgeSince
Charles Martin CEO
 Chief Executive Officer - 19-07-31
Brooke Martellaro DFI
 Director of Finance/CFO - 21-10-31
James Ott CTO
 Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Paul Danner CHM
 Chairman 64 21-09-30
Charles Martin CEO
 Chief Executive Officer - 19-07-31
Robert Kelley BRD
 Director/Board Member - -
More insiders

Company Profile

Sector
-
More about the company
  1. Stock Market
  2. Equities
  3. CBSC Stock